06-6372. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Tuberculosis Research Unit (TBRU).

    Date: August 10, 2006.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878.

    Contact Person: Darren D. Sledjeski, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 3253, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616. 301-451-2638. sledjeskid@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Unsolicited K99 Review.

    Date: August 11, 2006.

    Time: 12 p.m. to 2:30 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).

    Contact Person: Mercy R. Prabhudas, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-451-2615. mp457n@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, HIV Anti-Viral Drug Discovery P01.

    Date: August 17, 2006.

    Time: 9 a.m. to 12 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).

    Contact Person: Clayton C. Huntley, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-451-2570. chuntley@niaid.nih.gov.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Dated: July 14, 2006.

    Anna Snouffer,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 06-6372 Filed 7-19-06; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
8/10/2006
Published:
07/20/2006
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
06-6372
Dates:
August 10, 2006.
Pages:
41225-41225 (1 pages)
PDF File:
06-6372.pdf